p21/WAF1, p53 and PCNA expression and p53 mutation status in hepatocellular carcinoma.
about
KIAA0101 (OEACT-1), an expressionally down-regulated and growth-inhibitory gene in human hepatocellular carcinomaDDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth controlhSSB1 binds and protects p21 from ubiquitin-mediated degradation and positively correlates with p21 in human hepatocellular carcinomasCorrelation between expression of p53, p21/WAF1, and MDM2 proteins and their prognostic significance in primary hepatocellular carcinoma.Expression and prognostic role of molecular markers in 99 KIT-positive gastric stromal tumors in Taiwanese.Identification of FN1BP1 as a novel cell cycle regulator through modulating G1 checkpoint in human hepatocarcinoma Hep3B cellsImmunohistochemical Determination of p53 Protein Overexpression for Predicting p53 Gene Mutations in Hepatocellular Carcinoma: A Meta-Analysis.Effects of tachyplesin on proliferation and differentiation of human hepatocellular carcinoma SMMC-7721 cells.Reduced p21(WAF1/CIP1) protein expression is predominantly related to altered p53 in hepatocellular carcinomasDeletion of p21/Cdkn1a confers protective effect against prostate tumorigenesis in transgenic adenocarcinoma of the mouse prostate modelHepatocellular carcinoma: prevalence and molecular pathogenesis of Helicobacter spp.Significance of PRO2000/ANCCA expression, a novel proliferation-associated protein in hepatocellular carcinoma.A cyclin-dependent kinase inhibitor (p21(WAF1/CIP1)) affects thymidine incorporation in human liver cancer cellsHepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability.Ephrin-A1 expression contributes to the malignant characteristics of {alpha}-fetoprotein producing hepatocellular carcinoma.Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling.Chromosome alterations in human hepatocellular carcinomas correlate with aetiology and histological grade--results of an explorative CGH meta-analysis.Resistance of primary cultured mouse hepatic tumor cells to cellular senescence despite expression of p16(Ink4a), p19(Arf), p53, and p21(Waf1/Cip1).Hepatitis C virus-NS3P in relation to p53, p21waf, mdm2, p21-ras and c-erbB2 in hepatocarcinogenesis.Expression form of p53 and PCNA at the invasive front in oral squamous cell carcinoma: correlation with clinicopathological features and prognosis.Molecular and cellular pathology of hepatocellular carcinoma.Tyrosine kinase inhibitor PTK/ZK enhances the antitumor effects of interferon-α/5-fluorouracil therapy for hepatocellular carcinoma cells.Activation of cyclin-dependent kinases CDC2 and CDK2 in hepatocellular carcinoma
P2860
Q21260435-789E1537-B4D7-4CCC-A8D4-502B281A7040Q24296626-F1BFFF04-A1B6-4047-AB6A-7627D21BF6EDQ24337430-10DF1431-A2BC-4B47-9BF9-F63DB0189DF0Q33601430-E8D5022A-C265-4CAD-BC8E-EC643D1262D2Q33788333-3873CE71-9985-433B-BF18-A8CD88D0142AQ34612254-5DAB4616-145F-4D7A-8871-95AF7FEFB7C9Q36079974-BC9202C5-77B2-4BE4-B6F3-1EC6BE27DED2Q36308387-DCCCA5C8-49DD-4EB7-B15D-D36EE4ECEC59Q36641858-21DF8549-424C-479B-A574-2B64F1B3F9ADQ36923343-51F01DE4-F917-421D-85F7-069E8CA83F3AQ37648701-88D66092-7178-4ECC-9DAA-698EF832E530Q37719344-0C414974-ADFF-4C5F-9D2B-3E893565B108Q38282388-FA7DE542-7275-4AC4-81F7-46C6E48DAE37Q38309880-D0169845-28BE-4F53-9890-3633F2CFB7F0Q40423673-2508683A-4457-4B54-AD43-4475D43A9325Q40837817-C99CD396-FF63-4A21-A25E-7CE426001EECQ41886998-A1810321-9E7B-4D84-AD5A-F53678D37823Q43745848-BD72664F-2768-454A-BDBF-DED3D79D36D5Q45423117-2B16C6C2-4CE1-40BD-809C-90B4FCB01CC8Q46790752-92540736-35DD-4198-ADA3-6F04ADEE2081Q47672601-38FB5D9B-73AE-4791-9A22-E49966B4F454Q54652252-36AF5A48-2E04-4B70-80F7-68721E9ABDBDQ58327588-10F7F9AF-8605-405F-A4E9-3D44A1DDA109
P2860
p21/WAF1, p53 and PCNA expression and p53 mutation status in hepatocellular carcinoma.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
p21/WAF1, p53 and PCNA expression and p53 mutation status in hepatocellular carcinoma.
@en
p21/WAF1, p53 and PCNA expression and p53 mutation status in hepatocellular carcinoma.
@nl
type
label
p21/WAF1, p53 and PCNA expression and p53 mutation status in hepatocellular carcinoma.
@en
p21/WAF1, p53 and PCNA expression and p53 mutation status in hepatocellular carcinoma.
@nl
prefLabel
p21/WAF1, p53 and PCNA expression and p53 mutation status in hepatocellular carcinoma.
@en
p21/WAF1, p53 and PCNA expression and p53 mutation status in hepatocellular carcinoma.
@nl
P2093
P2860
P1476
p21/WAF1, p53 and PCNA expression and p53 mutation status in hepatocellular carcinoma.
@en
P2093
P2860
P304
P356
10.1002/(SICI)1097-0215(19980821)79:4<424::AID-IJC19>3.0.CO;2-4
P577
1998-08-01T00:00:00Z